Simultaneous binding of heme and Cu with amyloid β peptides: active site and reactivities

Arnab Kumar Nath1, Somdatta Ghosh Dey1

  • 1School of Chemical Sciences, Indian Association for the Cultivation of Science, 2A & 2B, Raja S. C. Mullick Road, Jadavpur, Kolkata 700032, India. icsgd@iacs.res.in.

Insights

Alzheimer's disease (AD) involves amyloid plaques with copper (Cu) and heme. This review explores the heme-Cu-Aβ complex, detailing its properties and reactions with small molecules like oxygen and nitric oxide.

Area of Science:

  • Biochemistry
  • Neuroscience
  • Metalloprotein chemistry

Background:

  • Alzheimer's disease (AD) is characterized by amyloid plaques.
  • These plaques show increased copper (Cu) and heme deposition.
  • Heme and Cu interact with amyloid-beta (Aβ) in AD pathology.

Purpose of the Study:

  • To review the properties of the heme-Cu-Aβ complex.
  • To discuss the complex's interactions with small molecules.
  • To explore the role of metal-cofactor binding in AD.

Main Methods:

  • Spectroscopic analysis of heme-Cu-Aβ complex.
  • Electrochemical studies of the complex.
  • Investigation of reactivity with O2, NO, and NO2-.

Main Results:

  • Heme and Cu bind separately and together with Aβ.
  • The heme-Cu-Aβ complex exhibits distinct electronic and spectroscopic properties.
  • The complex shows reactivity with oxygen, nitric oxide, and nitrite.

Conclusions:

  • The heme-Cu-Aβ complex is a relevant species in Alzheimer's disease.
  • Understanding its properties and reactivity offers insights into AD pathogenesis.
  • Metal-cofactor interactions in amyloid plaques are crucial for AD.

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
10.2K
Ligand Binding and Linkage00:49

Ligand Binding and Linkage

Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked.  In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
5.0K
Cooperative Allosteric Transitions01:58

Cooperative Allosteric Transitions

Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
8.1K
Allosteric Proteins-ATCase01:19

Allosteric Proteins-ATCase

Binding sites linkages can regulate a protein's function.  For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to  N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
5.9K